Axa SA (CS) Receives €26.17 Average PT from Brokerages

Shares of Axa SA (EPA:CS) have been given an average recommendation of “Buy” by the fourteen brokerages that are presently covering the stock, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 1 year price objective among brokers that have covered the stock in the last year is €26.21 ($30.47).

A number of research analysts have weighed in on CS shares. Barclays set a €24.00 ($27.91) price objective on shares of AXA and gave the company a “neutral” rating in a research note on Monday. Goldman Sachs Group set a €27.00 ($31.40) price objective on shares of AXA and gave the company a “buy” rating in a research note on Friday, February 22nd. UBS Group set a €21.00 ($24.42) price objective on shares of AXA and gave the company a “neutral” rating in a research note on Tuesday, February 12th. JPMorgan Chase & Co. set a €28.20 ($32.79) price objective on shares of AXA and gave the company a “buy” rating in a research note on Tuesday, January 29th. Finally, Deutsche Bank set a €24.00 ($27.91) price objective on shares of AXA and gave the company a “buy” rating in a research note on Monday, January 7th.

AXA has a 12 month low of €22.13 ($25.73) and a 12 month high of €27.69 ($32.20).

About AXA

AXA SA, through its subsidiaries, provides insurance and asset management services worldwide. It operates through six segments: France, Europe, Asia, the United States, International, and Transversal and Central Holdings. The company offers a range of insurance products, including life and savings, property and casualty, and health.

Featured Story: How do candlesticks reflect price movement?

Analyst Recommendations for AXA (EPA:CS)

Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit